Contemporary radiotherapy: present and future
Oncology care is increasingly a multidisciplinary endeavour, and radiation therapy
continues to have a key role across the disease spectrum in nearly every cancer. However …
continues to have a key role across the disease spectrum in nearly every cancer. However …
[HTML][HTML] Recent advances in the management of lung cancer
GS Jones, DR Baldwin - Clinical Medicine, 2018 - Elsevier
Historically, the prognosis for individuals diagnosed with lung cancer has been bleak.
However, the past 10 years have seen important advances in treatment and diagnosis which …
However, the past 10 years have seen important advances in treatment and diagnosis which …
[HTML][HTML] Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report
AMC Dingemans, LEL Hendriks, T Berghmans… - Journal of thoracic …, 2019 - Elsevier
Introduction Improved outcome has been shown in patients with synchronous
oligometastatic (sOM) NSCLC when treated with radical intent. As a uniform definition of …
oligometastatic (sOM) NSCLC when treated with radical intent. As a uniform definition of …
[HTML][HTML] The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer
WEE Eberhardt, A Mitchell, J Crowley, H Kondo… - Journal of thoracic …, 2015 - Elsevier
Introduction The aim of this study is to analyze all metastatic (M) categories of the current
tumor, node, and metastasis (TNM) classification of lung cancer with the objective of …
tumor, node, and metastasis (TNM) classification of lung cancer with the objective of …
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Primary lung cancer is the most common malignancy after nonmelanocytic skin cancer with
deaths from lung cancer exceeding those from any other type of malignancy worldwide [1] …
deaths from lung cancer exceeding those from any other type of malignancy worldwide [1] …
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non–small-cell lung cancer
Abstract Introduction/Background An individual patient data metaanalysis was performed to
determine clinical outcomes, and to propose a risk stratification system, related to the …
determine clinical outcomes, and to propose a risk stratification system, related to the …
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Primary lung cancer is the most common malignancy after non-melanocytic skin cancer, and
the leading cause of human cancer deaths worldwide [1]. While it has been the most …
the leading cause of human cancer deaths worldwide [1]. While it has been the most …
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins… - European urology, 2020 - Elsevier
Background Although guidelines exist for advanced and variant bladder cancer
management, evidence is limited/conflicting in some areas and the optimal approach …
management, evidence is limited/conflicting in some areas and the optimal approach …
The oligometastatic state—separating truth from wishful thinking
The oligometastatic paradigm implies that patients who develop a small number of
metastatic lesions might achieve long-term survival if all these lesions are ablated with …
metastatic lesions might achieve long-term survival if all these lesions are ablated with …